introduction session 4 | jordan feld, md, mph
Published 3 years ago • 38 plays • Length 18:15Download video MP4
Download video MP3
Similar videos
-
17:58
introduction of simplification - jordan feld
-
23:48
setting the stage - key challenges in elimination | jordan feld, md, mph
-
15:53
toxicity in new and established hbv compounds jordan feld, md, mph
-
18:39
what are the pros and cons of hbsag loss as the endpoint for treatment? | jordan feld, md, mph
-
45:45
session 4
-
24:41
how to combine new treatments? scientific approach | jordan feld, md, mph
-
28:49
minimising treatment duration and doses | jordan feld, md, mph
-
48:34
leaders of neurosurgery: teodoro dagi, md, faans interviewed by mark preul, md, faans
-
59:03
4d biology and cell dynamics: paving the way for personalized medicine
-
1:30:40
genomic medicine xv: research directions, summary and next steps
-
42:45
daa controversies: do they cause hbv reactivation and/or hcc? | jordan feld, md, mph
-
25:45
new treatment in hcv: is there need for more therapies? | jordan feld, md, mph
-
15:12
hypothesized synergies in new combination treatment beyond nucs - jordan feld
-
16:04
last year's key developments strenghthening elimination efforts - jordan feld
-
14:20
18- dr. jordan feld
-
55:31
opening session
-
17:54
4/6/17 - session 4: breakout introduction
-
1:04
meet neurologist hal blumenfeld, md, phd
-
5:30
majed jandali, m.d. physician profile video
-
10:48
establishing functional control of hbv and hdv infection with combination therapy | andrew vaillant
-
8:34
immunotherapeutics in the treatment of chronic hepatitis b - s. browne, md